chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; Itchiness at the injection site; redness on injection site; fatigue; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness on injection site), FATIGUE (fatigue) and CHILLS (Chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced MYALGIA (Body aches), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness on injection site), FATIGUE (fatigue), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (Body aches), FATIGUE (fatigue), CHILLS (Chills) and HEADACHE (Headache) had resolved and VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE ERYTHEMA (redness on injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications are not provided. Treatment information does not provided.
Several hours post vaccination. A Migraine Headache developed. The Migraine Headache has developed nearly every afternoon since the 2 nd dose vaccination. The migraine  headaches tend to last all afternoon. Dissipating during the evening.  Past migraine history is several migraines per week. Typically during weather activity. However these migraines are somewhat different than past migraines. More pain with less Aura or Vertigo. During past 20+ year?s patient history clusters have been relatively shorter in duration.
I received the pfizer covid vaccine booster and developed vitiligo in the weeks/months following due to the vaccine causing an autoimmune response in my body. I now have a progressive expensive incurable disease. the pfizer covid booster i received in 2022 caused the progressive disease vitiligo to develop and I am now suffering great mental anguish and expensive dr visits and medications.
Shingles; Information has been downloaded from Agency (US-BEH-2012033474).  This spontaneous report was received from a healthcare professional concerning to a male patient of unknown age. The patient's concurrent conditions, medical history, concomitant medications, previous drugs reactions and allergies were not reported.   On an unknown date, the patient was vaccinated with zoster vaccine live  (ZOSTAVAX), with a dose of 0.65 milliliter (ml), for immunization (strength, formulation, dose schedule, route of administration, anatomical site of injection and expiration date were not reported; lot number was unknown) and influenza virus vaccine (unspecified) (FLU VACCINE) (strength, formulation, dose, route of administration, anatomical site of injection and expiration date were not reported; lot number was unknown).   On an unknown date, the patient experienced herpes zoster.  The outcome of herpes zoster was reported as not resolved.        The causality assessment between all the suspect vaccines and the event of herpes zoster was not provided.   The event of herpes zoster was considered to be medically significant.
Extreme fatigue, headache, slightly felt strangled on and off, body aches, lymph nodes hurt, body felt heavy, foggy brain(felt slightly drugged on and off ), injection site felt stabbed. Started 4 hours after shot on Thursday evening and lasted until Saturday morning. Also Smelled chlorine in my nose in the beginning.
Fluid in lungs; This serious case was reported by a consumer via call center representative and described the occurrence of pulmonary edema in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, immediately after receiving Shingrix, [the patient experienced pulmonary edema (Verbatim: Fluid in lungs) (serious criteria GSK medically significant). The outcome of the pulmonary edema was unknown.   It was unknown if the reporter considered the pulmonary edema to be related to Shingrix.     It was unknown if the company considered the pulmonary edema to be related to Shingrix.   Additional Information: GSK Receipt Date: 14-MAR-2023 The patient was reporter's sister. The patient had fluid in lungs shortly after her Shingrix vaccine. Cause of her adverse event was unknown. The reporter collected only minimal information, as this information was just mentioned in passing, and the reporter did not know all the details.  The reporter did not request consent to contact the patient's doctor, as the reporter did not feel that the sister could provide it.  The reporter did not want to provide information on her sister.
patient had pain in the shoulder following the vaccination so she had gone to the dr to check on it she has an ultrasound scheduled for 1/13/2022
A female patient (age not reported), with no illness at the time of vaccination, had received a first dose, intramuscular injection of Adacel, lot number C2690AA, on 09 May 2007. At an unspecified amount of time post-vaccination, the patient experienced headache, swollen glands, and a temperature of 101.8 degrees Fahrenheit. The patient recovered from the event. The reporter in this case is the same as in cases 2007-02489, 2007-02495, 2007-02496, 2007-02497, and 2007-02499.
nausea, headache, chills, sweating, fever100.6, up all night with the same body pain all over my body like covid.
Patient received her first dose of Pfizer Covid-19 vaccine (lot EW0187) on 5/21/21 without incident. Patient received her second dose of the Pfizer Covid-19 vaccine (lot EW0127) on 6/11/21. About 45 minutes after the vaccine on 6/11/21, the patient had a syncopal episode and presented to the ER . On 6/12/21, the patient was found to have GI bleeding, including diarrhea with bright red blood noted.
Patient presented to pharmacy with unilateral shingles rash on left back and injection site. Dr. at clinic had given her a prescription for Acyclovir, NEURONTIN and LIDODERM. Rash had no blisters.
Pt states 4 hours after injection developed redness, hardness and swelling to site, muscle aches, neck and back hurting. By morning-pain in elbows, fever and legs feeling like jelly. Medicated with ibuprofen.
After administering the Vaxneuvance vaccine, I went to engage the safety needle and the syringe broke. The safety didn't engage, but I had moved it away from the patient and caregiver and nobody was injured.
Rash appeared at the injection site 1 week and 6 days after the injection.  Pt described the rash as smooth circles.  Pt described the area as warm but not itchy.
Myalgia, Arthralgia, Fever, Diarrhea, Stomachache, pain in mouth, mouth sore present, injection site pain radiating to neck
I was given two vaccines at the same time (FLU VACC 2022-2023 65+ YR, 0.5 ML, IM, ADJUVANTED, QUAD (FLUAD + SARS-COV-2 COVID-19 VACCINE 18+ YRS, BIVALENT 0.5ML, IM, MODERNA BOOSTER) and had/have reactions that continue including burning when breathing deep, lethargy, heart palpitations, and headaches. Vaccinations were given at MD office but given by Medical Assistant before I spoke with the MD. I was assured that two vaccines given at once were OK by the MA even when I questioned how that would be with an Emergency Use Booster. On 9/30/2022 I went to Urgent Care where APN examined me and said with tow vaccines he could not attribute symptoms with one or the other of the vaccines or the combination and to never get two vaccines at once. He noted ear wax blockage and had ears cleaned and prescribed NEO/HC 1% OTIC SOL BLUE drops but ear wax blockage existed before vaccinations. Symptoms continue as of the date of this complaint. Does the FDA allow combination vaccinations with the COVID boosters and if so, under what pretense?
Initial case received from a health care professional on 27 SEPTEMBER 2013. This female patient of unknown demographics whose medical history and concomitant medications were not reported had received FLUZONE 1 ml (route, lot number and anatomical site of administration not reported) on an unspecified date. On an unspecified date, after receiving FLUZONE the patient became pregnant. Patient's last date of menstruation, estimated date of delivery and pregnancy ongoing status was not reported. She did not experience any other event. No laboratory details were reported. List of documents held by sender: None.
The day following the vaccine the pt developed severe arthralgias and myalgias which have persisted.  The severity has decreased, but the pt still requires Ibuprofen for her discomfort/pain
Vasovagal response followed by repeated vomiting.  Patient was given ice packs and water and recovered within 15 minutes
Headache, Myalgia, Arthralgia, burning skin, skin peeling, soreness at injection site, fash rash, difficulty walking Narrative:
Narrative: patient received two doses of covid vaccine. Death reported on 3/9/2021 with death cert stating cause of death liver cancer. patient has no other documentation of death relating to vaccination. reporting per instructions.
This case was reported in a literature article and described the occurrence of uveitis in a 35-year-old female subject who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Patient vaccinated while in the hospital for Nondisplaced fracture of base of neck of right femur. Patient passed away in the hospital on 12/9/2021.
Vasovagal reaction, awaked quickly, tolerated , ambulates with difficulty, no further symptoms, no medication taken then released at 08: 30 AM
In Feb2021, the 59 year old caucasian female (who is a Registered Nurse), with a medical history:  Herpes Simplex 1, hypothyroid; Concomitant medications: Multivitamins, unspecified antiviral (for Herpes Simplex 1), received doses 1 and 2 of COVID-19 Pfizer vaccine IM in the arm 4 weeks apart and experienced arm pain/soreness which resolved a few days later. On 10Aug2021, she was experiencing flu-like symptoms such as runny nose, head ache, body aches, cough and took an over-the-counter (OTC) COVID test which returned a positive result. Of note, this patient travels a lot for work in air planes, hotels, rental cars as a registered nurse clinical monitor for the pharmaceutical industry and believes she may have been exposed to COVID-19 while working as an occupational hazard.  On 12Aug2021, she was still experiencing the runny nose, head ache, body aches, and a mild cough, was quarantining away from her family either in her bedroom or out back trying to get sunshine's vitamin D naturally. She noted that she was very glad to have been vaccinated and felt that her symptoms were less intense because she was vaccinated. By 22Aug2021, she appeared to be better and went to a family gathering. The reporter (Registered Nurse) and patient (Registered Nurse) both believed that the lack of effect and COVID-19 by Pfizer vaccination failure was absolutely related to the COVID-19 Pfizer vaccine.
Covid; Covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "immunocompromised" (unspecified if ongoing), notes: She also mentioned that both of them are immunocompromised. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200769678 Same reporter/vaccine/event, different patient
Public Health Dept received a Web report noting Patient was in-patient on 5/15/22 at Hospital. summary note: Patient presented to the ED with generalized weakness and multiple falls at home. Patient's wife is his caregiver. Patient fell out of bed and was not able to get up. EMS was called but not transported as the patient is doing well. Patient became progressively more weak and had another fall. No head trauma or loss consciousness. Patient was too weak to walk and wife cannot manage his care at home therefore he was brought to the ED for further evaluation. Patient tested positive for COVID. no further information known.
SHE CAME TO MY PHARMACY TODAY 5/5/16 AT 6:30 PM AND TOLD ME SHE HAS ALL THIS ADVERSE REACTION, HAS PAIN ON INJECTION SITE LEFT ARM, HOT, RED, SORES, HAS LOW {FEVER,HEADACHE AND EYE BURNING (ONLY LAST NIGHT 5/4/16 pm),},SHE STILL HAS LITTLE PAIN FROM LEFT SHOULDER TO NECK (BELOW HAIR LINE), AND RASH AND LITTLE SWELLING ON INJECTION SITE TODAY. I GIVE HER 25MG BENADRYL AND AN ICE PACK IMMEDIATELY, AND TOLD HER TO CONTINUE TAKE BENADRYL 25 MG EVERY 8 HRS AS NEEDED FOR ALLEGIC REACTION, ALSO APPLY ICE PACK FOR PAIN AND HOT AND SWELLING. TOLD HER TO CALL DOCTOR, AND ALSO CALL US BACK IF GET WORSE. -- SHE HAS NO BREATHING PROBLEM, ONLY COMPLAIN LOCALIZED DISCOMFORT TODAY.
Patient had 1st Moderna vaccine on 5/1/21 and after 9 days, the injection site started itching, swelling, red, and warm to touch. I recommended taking Benadryl and to contact her doctor. The patient contacted her doctor with a picture of the injection site. The doctor prescribed triamcinolone cream.
Fever; Headache; This is a spontaneous report from a contactable consumer (patient's niece). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 29Jan2021, at a single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's niece stated that the patient got the first Covid vaccine on 29Jan2021 and the patient was having fever and headache today, 18Feb2021. The niece wanted to know if the patient was having a reaction or if it could be Covid. The outcome of the events was unknown.  Information about the batch/lot number has been requested.
Muscle and joint pain with weakness in left arm.  The left elbow joint pain was so severe I was unable to flex my elbow to touch my face for over a week.  Also, have continued joint pain in my hips and back. The symptoms were expected but have continued for over 2 weeks.  The side effects after my first dose ( chills, muscle aches , headaches, fatigue and pain in my left arm) resolved completely after 72 hours.
This spontaneous report has been received from a 69 year old male patient, who was reporting on himself. The patient had a prior history of shingles. The patient had no drug reactions or allergies. Between May and June 2015, the patient was vaccinated in the left arm with an unknown dose of ZOSTAVAX as his healthcare professional (HCP) advised him to get the vaccination to prevent shingles to reappear (route, lot # and expiry date were not reported). Concomitant therapies included Aspirin (manufacturer unknown) and Vitamin B complex. In 2015, one week after vaccination, the patient experienced a slight itching reaction (did not disclose where the itching was), his blood pressure was either too high or too low and it became so low to the point that he passed out, he also had extreme numbness in his arms and legs and he definitely could not feel them. The patient did not seek medical attention and no treatment was given for the event. No lab diagnostics studies were performed. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Upon internal review, the event of passed out was considered to be medically significant. Additional information is not expected as the reporter did not wish to be contacted.
High Fever (103 F), intense shaking, chills, dizziness, weakness.
Warm, erythematous, inflammed skin covering 6cm x 5cm around injection site and BCG scar (left deltoid) seen 9/29/16 in office. Father reported that symptoms began 9/28/16.
I had a headache, muscle pain, joint pain, nasal congestion, runny nose, sneezing, coughing, chest discomfort, and fatigue. I found out I had COVID on December 16th. I had the anti body infusion on December 21st.
My left lymph node is inflamed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Nov2021 (Lot number: EW0186) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 immunization; Bnt162b2 (dose 2, single), for COVID-19 immunization. The following information was reported: LYMPHADENITIS (non-serious) with onset Nov2021, outcome "unknown", described as "My left lymph node is inflamed".  Additional Information: It was reported that, she just calling to report a side effect, she received the booster on Sunday 07Nov, in her left arm and she noticed yesterday as she came in from work and shower, that her left lymph node is inflamed. Reporter seriousness for her left lymph node is inflamed: Unspecified. Expiry Date of COVID-19 Vaccine: Unknown. Batch/lot number: EW0186  QR comment: Reporter type was not available over the call, hence captured as consumer or non-health professional by default.  No follow-up attempts are possible. No further information is expected.
Arm was very very sore and tender about one day after injection, and approximately one week after injection, a bruise appeared around the injection site and remained for approximately one week. I did not need to treat the bruise or seek professional medical aid. It eventually went away on its own and I have not noticed anything else around the site or had any related symptoms since.
Intermittent fevers X 1 year. She states symptoms started after receiving anthrax vaccination.
I feel arm snoring, high temperature, dryness and fever. I feel tired and very cold and my bones hurts. This began after 3 hours of my shot and continue until the moment of reporting.
Severe Chills and Body aches. Fever. Headache. Nausea. Overall weakness. Difficulty breathing.
Pt was given FluMist even though over 49 yrs old.  No adverse reactions known.
Patient received the 2nd dose of Moderna at the 21-day interval instead of 28-day interval.  No adverse event reported by the patient
Patient complained of "spotty vision", dizziness, sweating after getting her flu vaccine. Instructed to lie down. Was taken to health service where she was given liquids to drink. Recovered and discharged in 25 minutes.
A non-serious spontaneous report of a we gave expired H1N1 to several patients was received from a registered nurse/health professional concerning a 28-year-old female out of 17 patients. Neither relevant medical history nor concomitant medications have been reported for this patient. The vaccine expired on 15-Jan-2010. The original expiration date 12-Feb-2010, had been changed to 15-Jan-2010. On 20-Jan-2010, the patient received H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable and the event was considered recovered.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Sep2021 10:30 (Lot number: FF2587) at the age of 65 years as dose number unknown, single for Covid-19 immunisation. Relevant medical history included: "Donated kidney" (unspecified if ongoing). Concomitant medication(s) included: FLU VACCINE VII taken for immunisation, start date: 28Sep2021, stop date: 28Sep2021; BABY ASPIRIN. The following information was reported: TREMOR (non-serious) with onset 28Sep2021 23:00, outcome "recovered" (2021), described as "Sever shakes"; HYPERHIDROSIS (non-serious) with onset 28Sep2021 23:00, outcome "recovered" (2021), described as "sweating"; THIRST (non-serious) with onset 28Sep2021 23:00, outcome "recovered" (2021), described as "thirst"; BODY TEMPERATURE INCREASED (non-serious) with onset 28Sep2021 23:00, outcome "recovered" (2021), described as "positive big temperature swings"; CHILLS (non-serious) with onset 28Sep2021 23:00, outcome "recovered" (2021), described as "Chilled"; SOMNOLENCE (non-serious), GAIT DISTURBANCE (non-serious) all with onset 28Sep2021 23:00, outcome "recovered" (2021) and all described as "Next day could not stay awake or walk very far"; PRODUCT USE ISSUE (non-serious) with onset 28Sep2021 23:00, outcome "unknown", described as "patient received Pfizer COVID-19 vaccine and flu vaccine on same day". Therapeutic measures were not taken as a result of tremor, hyperhidrosis, thirst, body temperature increased, chills, somnolence, gait disturbance. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the patient received Baby aspirin within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination the patient has not been tested for COVID-19. It was reported that sever shakes, sweating, thirst. Starting about 12 hours post shot shaking so bad water flying out of glass - positive big temperature swings. Chilled. Next day could not stay awake or walk very far. It was reported that no treatment was received for the adverse event. No follow-up attempts are possible. No further information is expected.